| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $203K | -64.7% |
| Cost of Revenue | $203K | -64.7% |
| Gross Profit | $0 | — |
| R&D Expense | $3.4M | +74.6% |
| SG&A Expense | $3.1M | +29.7% |
| Operating Income | -$7.3M | -51.4% |
| Net Income | -$7.2M | -50.7% |
| EPS (Basic) | -$1.17 | -46.2% |
| EPS (Diluted) | -$1.17 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $16.3M | -29.5% |
| Accounts Receivable | $66K | -71.7% |
| Current Assets | $16.9M | -27.9% |
| Total Assets | $19.4M | -25.0% |
| Current Liabilities | $449K | -17.2% |
| Total Liabilities | $1.5M | -13.7% |
| Stockholders' Equity | $17.9M | -25.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.4M | -49.1% |
| Capital Expenditures | $183K | +312.6% |
| Investing Cash Flow | -$313K | -32.0% |
| Financing Cash Flow | -$128K | -100.5% |
| Free Cash Flow | -$6.6M | -51.8% |
| -46.2% |